BeOne Medicines (ONC) Current Leases (2019 - 2026)

BeOne Medicines (ONC) has 8 years of Current Leases data on file, last reported at $20.6 million in Q1 2026.

• Quarterly Current Leases rose 12.46% year-over-year to $20.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.6 million (up 12.46% YoY) and the FY2025 annual result came in at $20.7 million, up 17.76% from the prior year.
• Current Leases eased to $20.6 million in Q1 2026 per ONC's latest filing, from $20.7 million in the prior quarter.
• Across five years, Current Leases topped out at $24.8 million in Q2 2022 and bottomed at $15.7 million in Q3 2025.
• The 5-year median for Current Leases is $20.7 million (2025), against an average of $20.8 million.
• The widest annual swing landed in 2022, when Current Leases jumped 63.61%; it then slipped 24.89% in 2024.
• Tracing ONC's Current Leases over 5 years: stood at $24.0 million in 2022, then dropped by 8.7% to $22.0 million in 2023, then dropped by 19.93% to $17.6 million in 2024, then gained by 17.76% to $20.7 million in 2025, then fell by 0.55% to $20.6 million in 2026.
• Per Business Quant, the three latest ONC Current Leases figures stand at $20.6 million (Q1 2026), $20.7 million (Q4 2025), and $15.7 million (Q3 2025).

Peer Comparison